13-48303944-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000321.3(RB1):​c.32C>T​(p.Ala11Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000199 in 1,509,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A11T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 7.4e-7 ( 0 hom. )

Consequence

RB1
NM_000321.3 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.97

Publications

0 publications found
Variant links:
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
RB1-DT (HGNC:42778): (RB1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.114751935).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000321.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RB1
NM_000321.3
MANE Select
c.32C>Tp.Ala11Val
missense
Exon 1 of 27NP_000312.2
RB1
NM_001407165.1
c.32C>Tp.Ala11Val
missense
Exon 1 of 27NP_001394094.1
RB1
NM_001407166.1
c.32C>Tp.Ala11Val
missense
Exon 1 of 17NP_001394095.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RB1
ENST00000267163.6
TSL:1 MANE Select
c.32C>Tp.Ala11Val
missense
Exon 1 of 27ENSP00000267163.4
RB1
ENST00000467505.6
TSL:1
n.32C>T
non_coding_transcript_exon
Exon 1 of 22ENSP00000434702.1
RB1
ENST00000650461.1
c.32C>Tp.Ala11Val
missense
Exon 1 of 27ENSP00000497193.1

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151932
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD4 exome
AF:
7.37e-7
AC:
1
AN:
1357590
Hom.:
0
Cov.:
31
AF XY:
0.00000149
AC XY:
1
AN XY:
669668
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
27782
American (AMR)
AF:
0.00
AC:
0
AN:
33266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24204
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32412
South Asian (SAS)
AF:
0.0000131
AC:
1
AN:
76622
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34146
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4010
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1068592
Other (OTH)
AF:
0.00
AC:
0
AN:
56556
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151932
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41302
American (AMR)
AF:
0.0000655
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67954
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinoblastoma Uncertain:1
Jul 11, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with RB1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 11 of the RB1 protein (p.Ala11Val).

Hereditary cancer-predisposing syndrome Uncertain:1
Feb 03, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A11V variant (also known as c.32C>T), located in coding exon 1 of the RB1 gene, results from a C to T substitution at nucleotide position 32. The alanine at codon 11 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Uncertain
0.078
D
BayesDel_noAF
Benign
-0.13
CADD
Benign
16
DANN
Benign
0.94
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.67
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.071
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.0
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
0.18
N
REVEL
Benign
0.11
Sift
Benign
0.34
T
Sift4G
Benign
0.41
T
Polyphen
0.036
B
Vest4
0.20
MutPred
0.34
Loss of helix (P = 0.0626)
MVP
0.73
MPC
0.44
ClinPred
0.18
T
GERP RS
3.4
PromoterAI
-0.076
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.6
Varity_R
0.066
gMVP
0.17
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs899323337; hg19: chr13-48878080; API